logo
Mosquitoes bite! 5 tips for making yourself less attractive to them

Mosquitoes bite! 5 tips for making yourself less attractive to them

Yahoo5 days ago
EDITOR'S NOTE: The podcast Chasing Life With Dr. Sanjay Gupta explores the medical science behind some of life's mysteries big and small. You can listen to episodes here.
(CNN) — For summertime beachgoers, the threat of sharks may loom large, but nature's deadliest predator is actually much smaller.
The tiny mosquito is not only a warm-weather nuisance but also wears the crown for 'No. 1 killer of humanity across our existence,' according to historian Dr. Timothy C. Winegard. The predatory insect takes more than 1 million lives each year by transmitting lethal diseases. Sharks, meanwhile, are estimated to have a kill streak orders of magnitude smaller, at fewer than 10 people per year.
Where humans go, mosquitoes have followed. Their itchy bites and the disease-causing pathogens they carry are infamous, and the insects are also responsible for driving many of humanity's most essential turning points throughout history, said Winegard, author of 'The Mosquito: A Human History of Our Deadliest Predator.'
'Malaria and yellow fever (have shaped) our historical journey from our hominid ancestral evolution … right to present day,' Winegard told CNN Chief Medical Correspondent Dr. Sanjay Gupta recently on his podcast, Chasing Life.
Winegard, an associate professor of history at Colorado Mesa University, got the initial idea for his best-selling book from his dad's interest in malaria.
The wee pest didn't intrigue Winegard too much at first. 'I kind of disparaged him and said, 'Sure, dad, I'll write a book on mosquitoes,'' he recalled. But once Winegard began going down the rabbit hole of mosquito-borne pathogens' impact on humanity — including, but not limited to malaria, Zika virus, dengue fever, yellow fever, chikungunya and West Nile virus — he couldn't stop.
The mosquito's impact on history is still deeply felt in the present. More than half a million people die of malaria alone each year, and disease-heavy regions have suffered financially as a result. 'Northern Hemisphere countries don't have endemic malaria, (so) they're able to develop more affluent economies because they're not continuously suffering from malaria,' Winegard said.
You can listen to the full episode here.
Humans have been battling mosquitoes for millennia, and amid the season's summer peak in the Northern Hemisphere, Winegard offered some insight into how you can keep them away this summer.
'Eighty-five percent of what makes you alluring or less alluring to mosquitoes is prewired in your genetic circuit board,' according to Winegard. However, there are a few ways you can manage mosquitoes. He has these five tips.
Steer clear of the booze
Booze makes it easier for mosquitoes to see you, Winegard said.
Mosquitoes hunt by sight, but they don't see the world like people do. The predatory insects employ thermal, or infrared, vision. 'They see heat signatures,' Winegard noted.
'Consuming alcohol raises your body temperature,' he explained over email, 'which make(s) you an identifiable heat signature for your soon-to-be tormentor.'
So, maybe reach for a refreshing glass of water or lemonade instead of that beer.
Play it cool
In addition to using heat-based vision, mosquitoes hunt down humans primarily through smell.
Winegard said mosquitoes 'can smell carbon dioxide from over 200 feet (60 meters) away.'
'So if you're exercising or breathing heavily, they'll smell that and be attracted to it,' Winegard told Gupta.
And just like alcohol, high CO2 emissions make detecting heat signatures easier for mosquitoes, so Winegard recommends keeping yourself as cool as possible.
This applies to your wardrobe, too. 'Dark clothes retain relatively more heat,' he said, so it's best to opt for lighter-colored, long-sleeved attire to keep mosquitoes at bay.
Build a strong suit of armor
Applying insect repellent is the gold standard for mosquito management, but if you're not careful when applying it, you can leave yourself vulnerable to bites.
'I know people who lather themselves in it, but they miss this little spot on the back of their calf and she'll find the chink in our armor,' Winegard told Gupta, referring to the female mosquito, who is the bloodsucking hunter.
Mosquito repellent isn't like perfume, in which a few spritzes can cover your whole body. If you're spraying, make sure to be thorough.
'DEET (a chemical repellent) is still the gold standard, while oil of lemon eucalyptus is a plant-derived option,' Winegard said.
For an added boost of security, he noted some clothes come pretreated with a mosquito-targeted insecticide called permethrin.
Watch the water!
Pool days and cool drinks outdoors offer a respite from the heat for humans, but they are equally as attractive to mosquitoes. Female mosquitoes lay their eggs in still water — and they don't need much.
'From a pond or stream to a minuscule collection in the bottom of an old container, used tire, or backyard toy — even a bottle cap full — any will suffice,' Winegard said via email. Even waterlogged soil is enough for mom-to-be mosquitoes to lay their eggs in, he added.
Winegard recommended eliminating standing water around your home and yard to keep potential mosquito breeding grounds to a minimum.
Bring on the bacteria (but consider a foot bath)
Another way to fight the swarms this summer is to consider skipping a shower or two.
'It's better to be stinky!' Winegard said. 'Being pungently rancid is a good thing, for it increases bacterial levels on the skin, which makes you less alluring to mosquitoes.'
While this may offend others, Winegard says to skip the scented products: Deodorants, soaps and other applied fragrances are all enticing to mosquitoes.
The one exception is your feet. 'Clean your feet,' he told Gupta. 'The bacteria on our feet, which is the same one that ripens a lot of cheeses, is an aphrodisiac to mosquitoes.'
Winegard noted that this is the reason many of us get bitten around our ankles and feet. 'So, wash your feet!' he urged.
Check your blood type
Mosquitoes don't care about most personal characteristics you can objectively see.
'There is absolutely no truth to the persistent myths that mosquitoes fancy females over males, that they prefer blondes and redheads over those with darker hair, or that the darker or more leathery your skin, the safer you are from her bite,' Winegard said.
But he noted that 'she does play favorites and feasts on some more than others.'
What might entice a mosquito? 'Blood type O seems to be the vintage of choice over types A and B or their blend,' he said. 'People with blood type O get bitten twice as often as those with type A, with type B falling somewhere in between.'
The creators of the 1998 movie 'A Bug's Life,' he noted, must have 'done their homework when portraying a tipsy mosquito ordering a 'Bloody Mary, O-positive.''
Maybe it's a mosquito's world, Winegard suggests, and people are just living in it.
We hope these five tips help you keep mosquitoes at bay. Listen to the full episode here. And join us next week for a new episode of the Chasing Life podcast.
Solve the daily Crossword
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

eHealth (EHTH) Q2 Earnings Report Preview: What To Look For
eHealth (EHTH) Q2 Earnings Report Preview: What To Look For

Yahoo

time18 minutes ago

  • Yahoo

eHealth (EHTH) Q2 Earnings Report Preview: What To Look For

Online health insurance comparison site eHealth (NASDAQ:EHTH) will be reporting results this Wednesday morning. Here's what to expect. eHealth beat analysts' revenue expectations by 13.4% last quarter, reporting revenues of $113.1 million, up 21.7% year on year. It was an exceptional quarter for the company, with a solid beat of analysts' EBITDA estimates and full-year EBITDA guidance exceeding analysts' expectations. It reported 1.16 million users, down 1.8% year on year. Is eHealth a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting eHealth's revenue to decline 29.5% year on year to $46.41 million, a further deceleration from the 1.4% decrease it recorded in the same quarter last year. Adjusted loss is expected to come in at -$1.25 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. eHealth has a history of exceeding Wall Street's expectations, beating revenue estimates every single time over the past two years by 13.1% on average. Looking at eHealth's peers in the online marketplace segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Shutterstock delivered year-on-year revenue growth of 21.3%, beating analysts' expectations by 7.5%, and EverQuote reported revenues up 33.7%, in line with consensus estimates. Shutterstock's stock price was unchanged following the results. Read our full analysis of Shutterstock's results here and EverQuote's results here. Investors in the online marketplace segment have had steady hands going into earnings, with share prices up 1.5% on average over the last month. eHealth is down 22.5% during the same time and is heading into earnings with an average analyst price target of $10 (compared to the current share price of $3.21). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Sign in to access your portfolio

Long Covid Patients Can Sign up for Remote Clinical Trial Notification, Announces CareEvolution
Long Covid Patients Can Sign up for Remote Clinical Trial Notification, Announces CareEvolution

Yahoo

time18 minutes ago

  • Yahoo

Long Covid Patients Can Sign up for Remote Clinical Trial Notification, Announces CareEvolution

At-home participation in a study by Scripps Research and Schmidt Initiative for Long Covid powered by CareEvolution's MyDataHelps® platform ANN ARBOR, Mich., August 05, 2025--(BUSINESS WIRE)--Long Covid patients around the U.S. looking to participate in a clinical trial from home can sign up to be notified when an upcoming study conducted by scientists at Scripps Research and supported by the Schmidt Initiative for Long Covid (SILC) opens. Patients can sign up on the Long Covid Treatment Trial (LoCITT) website. The upcoming study, powered by the MyDataHelps platform from CareEvolution, is a fully remote clinical trial investigating the efficacy of a repurposed drug for treating Long COVID. It will enroll 1,000 Long Covid patients from across the U.S. The app-based study enables participants to enroll and participate in all trial activities without having to visit a trial clinic. "Decentralized trials broaden reach, speed timelines and yield richer real-world evidence," said Vik Kheterpal, MD, a principal at CareEvolution. "LoCITT will help advance how efficiently we can run trials as we seek treatments for complex, heterogeneous conditions like Long Covid." Long Covid, which has affected the lives of 400 million people worldwide and costs the global economy an estimated $1 trillion per year, can often cause symptoms that make mobility and travel challenging for patients who want to participate in trials. The forthcoming Scripps Research-led trial will rely on the LoCITT platform to enroll patients, distribute drug candidates and placebos, as well as collect and evaluate trial data. "For people with severe Long Covid, travel can be dangerous," said Julia Moore Vogel, senior program director at the Scripps Research Translational Institute. "LoCITT enables even patients with the most severe symptoms to join the search for answers." Moore Vogel is co-principal investigator of the study alongside Scripps Research executive vice president Eric Topol. Remote trials, which eliminate the need for patients to report to clinics, enable easier and broader participation. Conducting a Long Covid trial remotely will also allow more representative cohorts—potentially leading to more generalizable findings. "We need aggressive, rapid efforts to turn the tide on this very difficult condition for all the patients who struggle with it," said John Redd, CEO of SILC. "We're hopeful that a remote trial will help us find effective treatments more quickly." CareEvolution adapted its existing MyDataHelps decentralized clinical trial platform specifically for the LoCITT trial, with the potential for it to be used by other research efforts. The platform will allow for patients to be screened, enrolled and randomized more swiftly. Potential treatments and placebos will be mailed directly to the participant's home, along with wearable devices and other technologies to collect patient data. CareEvolution's user-friendly platform allows patients to check their eligibility, provide consent electronically and respond to baseline and ongoing surveys about their symptoms. Patients selected for the study will receive wrist devices to monitor their heart rates, activity and sleep, potentially enabling the development of digital biomarkers for Long Covid and related conditions like myalgic encephalomyelitis (ME), which can cause debilitating fatigue, and postural orthostatic tachycardia syndrome (POTS), which can cause dizziness, fatigue and a rapid heart rate upon standing up. The data from the devices will be uploaded to LoCITT. Prospective participants who are 18 years of age or older and who believe they have Long Covid can sign up at to be notified when the Scripps clinical trial opens. About CareEvolution We Connect Healthcare. MyDataHelps®, our digital clinical trials platform, accelerates healthcare innovation by empowering researchers to configure and launch studies in hours. We enable anyone, anywhere to be able to participate in research using participant centric design that integrates surveys, wearable and sensor data, EHR connectivity, and participant engagement tools to generate robust real-world longitudinal data. Trusted by over 2.5 million participants enrolled in longitudinal initiatives sponsored by health systems, academic institutions, life science companies, foundations, and public health agencies, CareEvolution advances precision health and helps close critical gaps in our collective understanding of complex conditions. For more information please visit About the Schmidt Initiative for Long Covid The Schmidt Initiative for Long Covid (SILC) advances clinical care for Long Covid patients globally. The nonprofit organization, founded in 2023 by philanthropists Eric and Wendy Schmidt, works to raise the level of Long Covid care and understanding around the world, connecting specialists and primary care providers to support patients and share knowledge virtually, in real time. For more information, visit About Scripps Research Scripps Research is an independent, nonprofit biomedical institute ranked one of the most influential in the world for its impact on innovation by Nature Index. We are advancing human health through profound discoveries that address pressing medical concerns around the globe. Our drug discovery and development division, Calibr-Skaggs, works hand-in-hand with scientists across disciplines to bring new medicines to patients as quickly and efficiently as possible, while teams at Scripps Research Translational Institute harness genomics, digital medicine and cutting-edge informatics to understand individual health and render more effective healthcare. Scripps Research also trains the next generation of leading scientists at our Skaggs Graduate School, consistently named among the top 10 US programs for chemistry and biological sciences. Learn more at View source version on Contacts CareEvolutionpr@ Swati Pandey, SILCspandey@ Anna Andersen, Scripps Researchaanders@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

These 5 Surprising Carbs Help You Stay Full and Stick to a Calorie Deficit, Trainer Says
These 5 Surprising Carbs Help You Stay Full and Stick to a Calorie Deficit, Trainer Says

Yahoo

time23 minutes ago

  • Yahoo

These 5 Surprising Carbs Help You Stay Full and Stick to a Calorie Deficit, Trainer Says

These 5 Surprising Carbs Help You Stay Full and Stick to a Calorie Deficit, Trainer Says originally appeared on Men's Fitness. Carbs are not the root of all evil. But when you're in a calorie deficit, they can feel off-limits. The truth is, carbs are the body's main source of fuel. They power our heavy lifting days, energize outdoor runs, and sustain us through everyday life. Still, some carb-heavy foods like bread can be calorie-dense and feel like a trap when you're trying to cut back. Trainer Dan Go shared five low-calorie carb sources that actually help keep you full while you're in a Carbs Potatoes "Potatoes are low in calories, high in fiber—especially with the skin. This makes them incredibly filling, and also their resistant starch and high water content helps you feel satisfied longer," Go says. Blueberries Blueberries may not be the first food that comes to mind when thinking about carbs. But, with their rich fiber and water content, they're a low-calorie carb that's highly satiating. The fiber in blueberries also slows digestion, which keeps you full and helps stabilize blood sugar. Lentils Lentils are small, but their fiber content is mighty. Along with its carb content, they're also a great source of plant protein, high in satiety. Broccoli "The reason I love broccoli is because it's one of the perfect foods to volumize your meals, because it contains a lot of fiber, a lot of water, and it helps you keep full while giving you an incredible nutrient profile," Go says. Rich in vitamin C, K, and folate, eating broccoli helps support your metabolism and digestion. Apples Go calls apples "nature's appetite suppressant." If you need a sweet treat during your calorie deficit, lean on apples. They're high in fiber and low in calories, helping you curb hunger and reduce snacking. Apples are also rich in 5 Surprising Carbs Help You Stay Full and Stick to a Calorie Deficit, Trainer Says first appeared on Men's Fitness on Jul 10, 2025 This story was originally reported by Men's Fitness on Jul 10, 2025, where it first appeared. Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store